Nicole Sweeny insider trades

Open-market stock purchases and sales by Nicole Sweeny, Director at Monopar Therapeutics, from SEC Form 4 filings since Feb 12, 2021.

Recent trades

DateStockTradeValue
Jun 26, 2026MNPR Monopar TherapeuticsBought (not open market)—
Jun 11, 2026KALV KalVista Pharmaceuticals, IncSold (not open market)—
Jun 11, 2026KALV KalVista Pharmaceuticals, IncSold (not open market)$951K
Jun 11, 2026KALV KalVista Pharmaceuticals, IncSold (not open market)—
Jun 11, 2026KALV KalVista Pharmaceuticals, IncSold (not open market)—
Jun 11, 2026KALV KalVista Pharmaceuticals, IncSold (not open market)—
May 26, 2026KALV KalVista Pharmaceuticals, IncSold$39.9K
May 22, 2026KALV KalVista Pharmaceuticals, IncSold$49.8K
May 22, 2026KALV KalVista Pharmaceuticals, IncBought (not open market)—
May 21, 2026KALV KalVista Pharmaceuticals, IncBought (not open market)—
Apr 17, 2026KALV KalVista Pharmaceuticals, IncSold$37.6K
Apr 16, 2026KALV KalVista Pharmaceuticals, IncBought (not open market)—
Feb 23, 2026KALV KalVista Pharmaceuticals, IncSold$61.9K
Feb 22, 2026KALV KalVista Pharmaceuticals, IncBought (not open market)—
Feb 21, 2026KALV KalVista Pharmaceuticals, IncBought (not open market)—
Jan 16, 2026KALV KalVista Pharmaceuticals, IncBought (not open market)—
Nov 24, 2025KALV KalVista Pharmaceuticals, IncSold$51.3K
Nov 22, 2025KALV KalVista Pharmaceuticals, IncBought (not open market)—
Nov 21, 2025KALV KalVista Pharmaceuticals, IncBought (not open market)—

Companies traded

  • MNPR Monopar Therapeutics: other filings, last Jun 26, 2026
  • KALV KalVista Pharmaceuticals, Inc: 7 sales, last Jun 11, 2026
  • PRAX Praxis Precision Medicines, Inc: other filings, last Feb 12, 2023

Get free alerts when Nicole Sweeny files a new trade →